Risk prediction model for early outcomes of revascularization for chronic limb-threatening ischaemia

T Miyata1, S Mii2, H Kumamaru3

  • 1Office of Medical Education, School of Medicine, International University of Health and Welfare, Chiba, Japan.

Insights

A new risk model accurately predicts 30-day outcomes for chronic limb-threatening ischemia (CLTI) patients undergoing revascularization. Key predictors include abnormal white blood cell count and emergency procedures, aiding treatment decisions.

Area of Science:

  • Vascular Surgery
  • Medical Informatics
  • Predictive Analytics

Background:

  • Chronic limb-threatening ischemia (CLTI) poses significant risks, necessitating accurate outcome prediction after revascularization.
  • Quantifying risks and benefits is crucial for optimizing treatment strategies in CLTI patients.
  • The JAPAN Critical Limb Ischemia Database (JCLIMB) provides valuable data for clinical research.

Purpose of the Study:

  • To develop and validate a risk prediction model for 30-day post-revascularization outcomes in CLTI patients.
  • To identify key predictors of major amputation/death and major adverse limb events.
  • To provide a tool for treatment decision-making and quality assessment in CLTI care.

Main Methods:

  • Utilized data from 2906 CLTI patients in the JCLIMB database (2013-2016).
  • Developed multivariable risk models using least absolute shrinkage and selection operator (LASSO) logistic regression.
  • Validated the model's performance using c-statistic and calibration plots.

Main Results:

  • The model predicted major amputation and/or death (5.0%) with a c-statistic of 0.82.
  • Predictors for amputation/death included abnormal white blood cell count, emergency procedures, heart failure, fever, and hemodialysis.
  • The model predicted major adverse limb events (6.4%) with a c-statistic of 0.79.
  • Predictors for adverse limb events included abnormal white blood cell count and fever.

Conclusions:

  • The developed risk prediction model demonstrates high accuracy for 30-day outcomes in CLTI patients.
  • This model can assist clinicians in selecting appropriate treatment strategies for CLTI.
  • The model may serve as a benchmark for evaluating the quality of care at medical facilities treating CLTI.
Abstract